MARKET

ABBV

ABBV

AbbVie
NYSE

Real-time Quotes | Nasdaq Last Sale

97.86
+1.03
+1.06%
After Hours: 98.50 +0.64 +0.65% 19:56 07/13 EDT
OPEN
97.36
PREV CLOSE
96.83
HIGH
99.56
LOW
96.92
VOLUME
8.51M
TURNOVER
--
52 WEEK HIGH
100.69
52 WEEK LOW
62.55
MARKET CAP
172.46B
P/E (TTM)
17.32
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ABBV stock price target is 104.44 with a high estimate of 125.00 and a low estimate of 70.00.

EPS

ABBV News

More
ClearBridge Multi Cap Growth Strategy Portfolio Manager Commentary Q2 2020
Seeking Alpha - Article · 2d ago
Dividend Challenger Highlights: Week Of July 12
Seeking Alpha - Article · 2d ago
AbbVie (ABBV) Gets FDA Nod for Another Botox Label Expansion
Zacks · 3d ago
AbbVie Is About To Break Out
Seeking Alpha - Article · 3d ago
Top Ranked Income Stocks to Buy for July 10th
Zacks · 3d ago
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Benzinga · 3d ago
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 3d ago
FDA OKs expanded use of Allergan' Botox for pediatric patients with muscle stiffness
Seeking Alpha - Article · 3d ago

Industry

Pharmaceuticals
+0.63%
Pharmaceuticals & Medical Research
-0.02%

Hot Stocks

Symbol
Price
%Change

About ABBV

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
More

Webull offers kinds of AbbVie Inc stock information, including NYSE:ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.